mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-09 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |